Hyperuricemia

• FDA approval · 2009-01-23
  FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for Allopurinol submitted by Actavis Pharma, Inc.

• FDA approval · 2008-05-13
  FDA Approved: PROBENECID AND COLCHICINE — Original Application (Ingenus Pharmaceuticals, LLC)

  FDA approved Ingenus Pharmaceuticals' generic Probenecid and Colchicine as an original ANDA.

• CLINICAL_TRIALS trial_result · 2008-01-28
  Clinical Trial Update: Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome [Phase 4]

  Phase 4 clinical trial evaluating rasburicase for treatment of hyperuricemia in children and adolescents with tumor lysis syndrome has compl…

• FDA approval · 2007-08-22
  FDA Approved: ALLOPURINOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for allopurinol (ALLOPURINOL) from Sun Pharmaceutical Industries, Inc. The action represents a regul…

• CLINICAL_TRIALS trial_result · 2007-01-15
  Clinical Trial Update: Treatment of Hyperuricemia in Patients With Heart Failure [Phase 4]

  Phase 4 clinical trial investigating treatment of hyperuricemia in patients with heart failure has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-05-15
  FDA Approved: PROBENECID — Supplemental Application (Lannett Company, Inc.)

  FDA has approved a supplemental application for Probenecid from Lannett Company, Inc., confirming the supplemental regulatory action on this…